Neuropeptide alpha-MSH exerts pro-inflammatory effects on Neisseria meningitidis infection in vitro

Pawan Kumar1, Jeannette N Williams, Kesta L Durkin

  • 1Division of Infection, Inflammation and Immunity, Department of Dermatopharmacology, University of Southampton Medical School, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK.

Abstract

Insights

Alpha-melanocyte stimulating hormone (alpha-MSH) increased inflammation and bacterial adherence in meningococcal meningitis models. This neuropeptide is not suitable for treating meningitis due to these pro-inflammatory effects.

Area of Science:

  • Neuroimmunology
  • Microbiology

Background:

  • Alpha-melanocyte stimulating hormone (alpha-MSH) is a neuropeptide with known antimicrobial and immunomodulatory properties.
  • Alpha-MSH has been detected in cerebrospinal fluid of children with bacterial meningitis.

Purpose of the Study:

  • To investigate the therapeutic effects of alpha-MSH on Neisseria meningitidis infection in human meningeal cell cultures.
  • To assess the impact of alpha-MSH on bacterial adherence, cytokine production, and antimicrobial activity in vitro.

Main Methods:

  • Human meningeal cell lines were infected with Neisseria meningitidis, bacterial outer membranes, or lipo-oligosaccharide (LOS).
  • Cells were treated with varying concentrations of alpha-MSH.
  • Bacterial adherence, cytokine secretion (IL-6, IL-8, RANTES, GM-CSF), and antimicrobial activity were measured.

Main Results:

  • Alpha-MSH (10 microM) significantly upregulated secretion of IL-6, IL-8, RANTES, and GM-CSF.
  • Upregulated cytokine secretion correlated with a >5-fold increase in bacterial adherence, dependent on outer membrane components and LOS.
  • Neisseria meningitidis showed resistance to the antimicrobial activity of alpha-MSH at all tested concentrations.

Conclusions:

  • Alpha-MSH exhibits pro-inflammatory effects in vitro during meningococcal infection.
  • The synergistic action of alpha-MSH with bacterial components enhances adherence.
  • Alpha-MSH administration is contraindicated for the treatment of meningitis.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...